Albemarle Corporation to Attend Citi's Chemicals Conference
Get Alerts ALB Hot Sheet
Join SI Premium – FREE
CHARLOTTE, N.C., May 29, 2018 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that Eric Norris, Chief Strategy Officer, Sharon McGee, Vice President - Corporate Development and Investor Relations, and Mark de Boer, Director Corporate Strategy and Investor Relations, will attend Citi's Chemicals Conference in London on Thursday, June 21, 2018 for one-on-one meetings.

About AlbemarleAlbemarle Corporation (NYSE: ALB), headquartered in Charlotte, NC, is a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts. We power the potential of companies in many of the world's largest and most critical industries, from energy and communications to transportation and electronics. Working side-by-side with our customers, we develop value-added, customized solutions that make them more competitive. Our solutions combine the finest technology and ingredients with the knowledge and know-how of our highly experienced and talented team of operators, scientists and engineers.
Discovering and implementing new and better performance-based sustainable solutions is what motivates all of us. We think beyond business-as-usual to drive innovations that create lasting value. Albemarle employs approximately 5,400 people and serves customers in approximately 100 countries. We regularly post information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, non-GAAP reconciliations, SEC filings and other information regarding our company, its businesses and the markets it serves.
View original content with multimedia:http://www.prnewswire.com/news-releases/albemarle-corporation-to-attend-citis-chemicals-conference-300655303.html
SOURCE Albemarle Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- Kairos Pharma announces 1-for-7 reverse stock split
- CoStar Group acquires Zonda for $800M, adding new home data
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share